<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJNeph</journal-id><journal-title-group><journal-title>Open Journal of Nephrology</journal-title></journal-title-group><issn pub-type="epub">2164-2842</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojneph.2024.141007</article-id><article-id pub-id-type="publisher-id">OJNeph-131374</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Epidemiological, Clinical, Therapeutic, and Evolutionary Aspects of Chronic End-Stage Renal Failure in the Nephrology Department of the University Hospital of Brazzaville in 2023
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ga&amp;euml;l</surname><given-names>Honal Mahoungou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Daniel</surname><given-names>Tony Eyeni Sinomono</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Éric</surname><given-names>Ngandzali-Ngabé</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Soraya</surname><given-names>Ntandou</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Francky</surname><given-names>Ambounou</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Précieux</surname><given-names>Ngoma</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Berline</surname><given-names>Ndinga</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dalhia</surname><given-names>Mboungou</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Héléna</surname><given-names>Botokoto Bothard</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hardy</surname><given-names>Ibovi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Richard</surname><given-names>Loumingou</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Faculty of Health Sciences, Marien Ngouabi University, Brazzaville, Congo</addr-line></aff><aff id="aff2"><addr-line>Department of Nephrology, University Hospital of Brazzaville, Brazzaville, Congo</addr-line></aff><pub-date pub-type="epub"><day>10</day><month>01</month><year>2024</year></pub-date><volume>14</volume><issue>01</issue><fpage>62</fpage><lpage>69</lpage><history><date date-type="received"><day>29,</day>	<month>January</month>	<year>2024</year></date><date date-type="rev-recd"><day>24,</day>	<month>February</month>	<year>2024</year>	</date><date date-type="accepted"><day>27,</day>	<month>February</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Objective: Chronic end-stage renal failure is a major public health problem in developing countries and is poorly documented. The objective of this study was to describe the epidemiological, diagnostic, therapeutic, and evolutionary aspects of patients admitted for end-stage renal failure to the Department of Nephrology at the University Hospital of Brazzaville. 
  Patients and Methods: This was a descriptive cross-sectional study collecting prospective data that took place over 10 months. We included 128 patients who were exhaustively identified. Sociodemographic, clinical, therapeutic and developmental data were collected using a standardized and pretested pre-established survey form. The EPI info software enabled the analysis and processing of the data. 
  Results: We reported a male predominance with a sex ratio of 2.5. The median age was 50 years. The first cause found was diabetes (55%) followed by hypertension (46%). The majority of patients had a dialysis emergency and half could not be dialyzed for financial reasons. 
  Conclusion: Our results highlighted that certain epidemiological parameters of end-stage renal failure are constantly changing, such as frequency, while others remain static, including the main etiologies, gender, and age. However, mortality continues to increase and deserves more attention.
 
</p></abstract><kwd-group><kwd>ESRD</kwd><kwd> Epidemiology</kwd><kwd> Nephrology</kwd><kwd> University Hospital of Brazzaville</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Chronic kidney failure (CKD) is defined as a set of abnormalities in kidney structure or function present for more than three months [<xref ref-type="bibr" rid="scirp.131374-ref1">1</xref>] . It is called a terminal when the glomerular filtration rate is less than 15 ml/min/1.73m<sup>2</sup> [<xref ref-type="bibr" rid="scirp.131374-ref1">1</xref>] . End-stage chronic kidney disease (ESRD) is a real scourge in the world. The incidence of end-stage kidney disease is anticipated to significantly increase in the coming decades, primarily due to the aging population and a growing prevalence of diabetes and hypertension. This demographic shift is expected to be more pronounced in developing countries rather than developed ones, posing economic challenges for many nations in delivering renal replacement therapy to a growing population of individuals with end-stage kidney disease. In 2015, it was estimated that around 2.6 million people worldwide had ESRD and that more than 2.2 million patients may have died due to a lack of access to replacement therapy [<xref ref-type="bibr" rid="scirp.131374-ref2">2</xref>] . In 2021 in Brazzaville, end-stage chronic renal failure represented 72.5% of cases of chronic renal failure, with an overall annual cost of dialysis treatment estimated at 7,569,600 CFA Francs average per person or 12581.685 USD [<xref ref-type="bibr" rid="scirp.131374-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.131374-ref4">4</xref>] .</p><p>Many patients arrive at the hospital straight away at this terminal stage of the disease. This could be partly explained by late consultation, the low socio-economic level of the population and the insufficient number of nephrologists. The high cost of treatments, ineffective health policies, and insufficient technical support in public hospital structures could contribute to the morbidity and mortality of the disease.</p><p>To better understand the main areas of management of ESRD in the Republic of Congo, we set ourselves the objective of describing the epidemiological, diagnostic, therapeutic, and evolutionary profile of end-stage chronic renal failure in Brazzaville.</p></sec><sec id="s2"><title>2. Patients and Method</title><p>This was a descriptive cross-sectional study carried out in the Nephrology department of the Brazzaville University Hospital (Republic of Congo) from January 1, 2023 to October 30, 2023, i.e., a duration of 10 months.</p><p>The diagnosis of ESRD was made according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria [<xref ref-type="bibr" rid="scirp.131374-ref1">1</xref>] . The glomerular filtration rate (GFR) was calculated according to the MDRD (Modification of diet in renal disease) formula, which allowed us to stage the disease according to the KDIGO [<xref ref-type="bibr" rid="scirp.131374-ref1">1</xref>] .</p><p>In view of the preceding elements, we included in the study adults of both sexes with or without a history of kidney disease whose diagnosis of ESRD was made during the study period.</p><p>We excluded all patients with a GFR greater than 15 ml/min/1.73m<sup>2</sup> at least three months after inclusion in the study.</p><p>The parameters studied were age, sex, professional status, socioeconomic level, the probable cause of ESRD, comorbidities, circumstances of the discovery of the disease, GFR, therapeutic attitude, and evolution.</p><p>We used Epi info 7.1 software to create the database and statistical analyses.</p></sec><sec id="s3"><title>3. Results</title><p>During the study period, 286 CKD patients were hospitalized, and 128 presented with CKD, representing a frequency of 44.75%. The study population consisted of 91 (71.1%) men and 37 (28.9%) women, i.e. a sex ratio of 2.5.</p><p>The median age was 50 years with extremes of 21 and 81 years. Patients under 60 years old were the most represented.</p><p><xref ref-type="table" rid="table1">Table 1</xref> shows the distribution of patients by age group.</p><p>Unemployed patients were the most represented. The socio-economic level was low in 70.3%, medium in 26.6% and high in 3.1%.</p><p><xref ref-type="fig" rid="fig1">Figure 1</xref> shows the distribution of patients according to professional status.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of patients by age groups (in years)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Effective</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Age groups</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;30</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >10.2</td></tr><tr><td align="center" valign="middle" >30 - 39</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >10.9</td></tr><tr><td align="center" valign="middle" >40 - 49</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >23.4</td></tr><tr><td align="center" valign="middle" >50 - 59</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >21.9</td></tr><tr><td align="center" valign="middle" >≥60</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >33.6</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >128</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><p>The uremic syndrome was the most frequent discovery circumstance in 68% followed by pulmonary edema (34.4%), edematous syndrome (23.4%), and anemia (1.6%). <xref ref-type="fig" rid="fig2">Figure 2</xref> presents the distribution of patients according to the circumstances of the discovery of CKD.</p><p>Diabetes and high blood pressure were respectively the leading causes of end-stage chronic renal failure.</p><p><xref ref-type="fig" rid="fig3">Figure 3</xref> illustrates the different etiologies of ESRD during our study.</p><p>Conditions found in our study population with ESRD were hypertension, diabetes HIV, benign prostatic hypertrophy, prostate cancer, and heart disease. <xref ref-type="table" rid="table2">Table 2</xref> summarizes all the comorbidities found in the study population.</p><p>The distribution of patients according to GFR is presented in <xref ref-type="fig" rid="fig4">Figure 4</xref>. Overall, 37% of participants had GFR lower than 5 mL/min, 34% had GFR 10 - 14 mL/min, 29% had GFR 5 - 9 mL/min.</p><p>All patients had an indication for dialysis, among whom 78% had a dialysis emergency. Some patients had several indications for dialysis at the same time. Sixty-five patients (50.8%) in total were able to be dialyzed compared to 63 (49.2%) who could not for financial reasons. The distribution of patients according to dialysis emergency is shown in the <xref ref-type="table" rid="table3">Table 3</xref> below.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of patients according to comorbidities</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Effective</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Comorbidities</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >HTN</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >54.7</td></tr><tr><td align="center" valign="middle" >Diabetes</td><td align="center" valign="middle" >55</td><td align="center" valign="middle" >43</td></tr><tr><td align="center" valign="middle" >HIV</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >Benign prostatic hypertrophy</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >3.9</td></tr><tr><td align="center" valign="middle" >Prostate cancer</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >3.1</td></tr><tr><td align="center" valign="middle" >Heart disease</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.6</td></tr><tr><td align="center" valign="middle" >Chronic smoking</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.6</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >128</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of patients according to comorbidities</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Effective</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Dialysis emergencies</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Uremic syndrome</td><td align="center" valign="middle" >83</td><td align="center" valign="middle" >64.8</td></tr><tr><td align="center" valign="middle" >Threatening hyperkalemia</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >23.4</td></tr><tr><td align="center" valign="middle" >Severe metabolic acidosis</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >30.46</td></tr><tr><td align="center" valign="middle" >Acute pulmonary edema</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >34.4</td></tr></tbody></table></table-wrap><p>During our work, 83 patients died, giving a specific mortality rate of 64.8%.</p></sec><sec id="s4"><title>4. Discussion</title><p>The enthusiasm surrounding chronic end-stage renal failure is not trivial. Its epidemiology is constantly in flux, varying from one country to another or from one period to another. The nephrology and dialysis department of the University Hospital of Brazzaville was chosen as the location of the study because it is the only department specialized in the management of kidney diseases in the entire city of Brazzaville.</p><p>The frequency of ESRD in our study is far from that reported by EYENI et al. in 2021, thus explaining the periodic epidemiological variabilities of the pathology, even within the same region [<xref ref-type="bibr" rid="scirp.131374-ref3">3</xref>] .</p><p>The male predominance of the disease is a frequent phenomenon, it is comparable to that of Eyeni and Mahoungou in 2021 who found a sex ratio of 1.6 and 2.13 respectively [<xref ref-type="bibr" rid="scirp.131374-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.131374-ref5">5</xref>] . Male predominance is an epidemiological constant found in other African studies [<xref ref-type="bibr" rid="scirp.131374-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.131374-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.131374-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.131374-ref9">9</xref>] .</p><p>The median age in our study was 50 years. Patients under 60 years old were the most represented, with a proportion of 66.4%. Bourhaima et al. in Treichville noted an average age of 44 year [<xref ref-type="bibr" rid="scirp.131374-ref10">10</xref>] . Kaba et al. in 2015 reported a median age of 44 years in Conakry [<xref ref-type="bibr" rid="scirp.131374-ref11">11</xref>] . Yawovi Mawufemo et al. in 2020 in Lom&#233; found a median age of 49 year [<xref ref-type="bibr" rid="scirp.131374-ref12">12</xref>] .</p><p>It is therefore a pathology of young adults, reflecting the population of Africa which is predominantly young. Contrary to African data, in developed countries CKD is a pathology of the elderly. In 2017 in France, the average age of patients treated for ESRD was 70.5 years [<xref ref-type="bibr" rid="scirp.131374-ref13">13</xref>] . This can be explained by the fact that in the West disease prevention policies are effective, thus delaying the arrival at the terminal stage.</p><p>The leading cause of ESRD in our study was diabetes (55%) followed by hypertension (46%). These results are similar to those of Eyeni et al. in 2021 in Congo [<xref ref-type="bibr" rid="scirp.131374-ref3">3</xref>] . Diabetes is a scourge in the Republic of Congo, its constantly increasing prevalence would explain the fact that it is the leading cause of ESRD in our context. These results are similar to those of Middle Eastern countries [<xref ref-type="bibr" rid="scirp.131374-ref14">14</xref>] .</p><p>ESRD was mainly discovered in a dialytic emergency context which could be explained by the diagnostic delay in our countries. The uremic syndrome (64.8%) followed by OAP (34.4%) were the main emergencies. These results are similar to those reported by MAHOUNGOU et al. with uremic syndrome and PAO as the two main dialysis emergency [<xref ref-type="bibr" rid="scirp.131374-ref5">5</xref>] . Our results are also superimposable to those found by DIAWARA et al. in Senegal in 2020 and KONAN et al. in Ivory Coast in 2021 in whom poorly tolerated uremia was also the main indication for hemodialysis [<xref ref-type="bibr" rid="scirp.131374-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.131374-ref16">16</xref>] .</p><p>Only 50.8% of patients had benefited from replacement treatment by hemodialysis for financial reasons. In Brazzaville, there are no hemodialysis units in the public sector. All the centers listed in this city are all private, with an average cost of the hemodialysis session estimated at 165,800 CFA Francs (270 US Dollars) [<xref ref-type="bibr" rid="scirp.131374-ref17">17</xref>] . The only public center in Congo is located in the town of Oyo, nearly 400 km from Brazzaville.</p><p>Eighty-three patients died, giving a case fatality rate of 64.8%. Our results are among the highest in Africa, some African series have results far from ours [<xref ref-type="bibr" rid="scirp.131374-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.131374-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.131374-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.131374-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.131374-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.131374-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.131374-ref21">21</xref>] . The exorbitant cost of care, the low socio-economic level of the population and ineffective health policies could explain this mortality.</p><p>The monocentric nature of our work was a limitation for our work because it did not allow us to extrapolate our data to a national scale.</p></sec><sec id="s5"><title>5. Conclusion</title><p>The problems that undermine the management of ESRD in the Republic of Congo remain the same. The frequency of this pathology remains variable, young adults are the most affected with a male predominance. Patients with a low socio-economic level were the most represented. Diabetes and hypertension are the main causes. The majority of patients needed emergency dialysis. Inaccessibility to hemodialysis was encountered in almost half of the study population, which contributed to high mortality.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Mahoungou, G.H., Sinomono, D.T.E., Ngandzali-Ngab&#233;, &#201;., Ntandou, S., Ambounou, F., Ngoma, P., Ndinga, B., Mboungou, D., Bothard, H.B., Ibovi, H. and Loumingou, R. (2024) Epidemiological, Clinical, Therapeutic, and Evolutionary Aspects of Chronic End-Stage Renal Failure in the Nephrology Department of the University Hospital of Brazzaville in 2023. Open Journal of Nephrology, 14, 62-69. https://doi.org/10.4236/ojneph.2023.141007</p></sec></body><back><ref-list><title>References</title><ref id="scirp.131374-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">(2023) KDIGO 2023 CKD Guideline Public Review Draft 5 July 2023.https://www.scribd.com/document/660236684/KDIGO-2023-CKD-Guideline-Public-Review-Draft-5-July-2023</mixed-citation></ref><ref id="scirp.131374-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Liyanage, T., Ninomiya, T., Jha, V., Neal, B., Patrice, H.M., Okpechi, I., et al. (2015) Worldwide Access to Treatment for End-Stage Kidney Disease: A Systematic Review. The Lancet, 385, 1975-1982. https://doi.org/10.1016/S0140-6736(14)61601-9</mixed-citation></ref><ref id="scirp.131374-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Eyeni Sinomono, T., Loumingou, R., Koumou, G.C.G., Mahoungou, G.H. and Mobengo, J.L. (2021) Chronic Renal Failure at Brazzaville University Hospital: Epidemiology, Diagnosis and Evolution. Health Sciences and Disease, 22. http://www.hsd-fmsb.org/index.php/hsd/article/view/2478</mixed-citation></ref><ref id="scirp.131374-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Mahoungou, G.H., Eyeni Sinomono, D.T., Clauvel Niama, A., Ngoma, P., Gandzali-Ngabé, E., et al. (2023) Cost of Therapeutic Care for Patients on Maintenance Hemodialysis in a Public Hospital in Congo Brazzaville in 2022. International Journal of Nephrology and Kidney Failure, 9. https://doi.org/10.16966/2380-5498.241</mixed-citation></ref><ref id="scirp.131374-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Mahoungou, G., Eyeni Sinomono, D.T., et al. (2021) Dialysis Emergencies: Epidemiological, Clinical, Etiological and Progressive Aspects. https://www.em-consulte.com/article/1468724/les-urgences-dialyses-epidemiological-aspects</mixed-citation></ref><ref id="scirp.131374-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Nlandu, Y., Hamaz, S., Robert, A., Cheddani, L., Vilaine, è., Seidowsky, A., et al. (2020) End-Stage Renal Failure in the Maghreb and Africa: Overview of Transplantation Programs in the Maghreb and Africa. Therapeutic Nephrology, 16, 171-176. https://doi.org/10.1016/j.nephro.2019.08.001</mixed-citation></ref><ref id="scirp.131374-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Tia, M.W., Nda, J.K., Kouame, G.R., Kobenan, R., Daingui, D. and Ouattara, B. (2022) Chronic Renal Failure: Epidemiological, Diagnostic, Therapeutic and Evolving Aspects at Bouaké University Hospital from 2016 to 2020. Revue Africaine de Médecine Interne, 9, 60-66.</mixed-citation></ref><ref id="scirp.131374-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Asserraji, M., Maoujoud, O., Belarbi, M. and Oualim, Z. (2015) Epidemiological Profile of End-Stage Renal Failure at the Military Hospital of Rabat, Morocco. Pan African Medical Journal, 20, Article 439. https://doi.org/10.11604/pamj.2015.20.439.3352 http://www.panafrican-med-journal.com/content/article/20/439/full/</mixed-citation></ref><ref id="scirp.131374-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Mechri, A., Chermiti, M., Elloumi, Z. and Gorsane, I. (2020) Epidemiological Profile of Chronic End-Stage Renal Failure in the KEF Governorate in North-West Tunisia. Therapeutic Nephrology, 16, 327-328. https://doi.org/10.1016/j.nephro.2020.07.206</mixed-citation></ref><ref id="scirp.131374-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Ouattara, B., Kra, O., Yao, H., Kadjo, K. and Niamkey, E.K. (2011) Particularities of Chronic Renal Failure in Black Adult Patients Hospitalized in the Internal Medicine Department of the Treichville University Hospital. Therapeutic Nephrology, 7, 531-534. https://doi.org/10.1016/j.nephro.2011.03.009</mixed-citation></ref><ref id="scirp.131374-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Kaba, M.L., Amm, N., et al. (2015) Prevalence of End-Stage Chronic Renal Failure Treated in Conakry. Therapeutic Nephrology, 11, 362. https://doi.org/10.1016/j.nephro.2015.07.310</mixed-citation></ref><ref id="scirp.131374-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Delma, S., Ouedraogo, S., Bonzi, Y.J., Kone-Sigue, M., Yanogo, D. and Coulibaly, G. (2020) Epidemioclinical Profile of Chronic Hemodialysis Patients at Tengandogo University Hospital, Ouagadougou. Mali Medical, 35, 6-9.</mixed-citation></ref><ref id="scirp.131374-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Safon, M.O. (2018) L’insuffisance rénale chronique et terminale (IRC/IRCT) épidémiologie, co&amp;ucirc;t et parcours de soins Bibliographie thématique Centre de documentation de l’Irdes. http://www.irdes.fr/documentation/syntheses/</mixed-citation></ref><ref id="scirp.131374-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Shaheen, F.A.M., Al-Attar, B., Ahmad, M.K. and Follero, P.M. (2020) Burden of Disease: Prevalence and Incidence of Endstage Renal Disease in Middle Eastern Countries. Clinical Nephrology, 93, 120-123. https://doi.org/10.5414/CNP92S121</mixed-citation></ref><ref id="scirp.131374-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Mame Selly, D., Yaya, K., Moustapha, C.M., Tall, L.A., Maria, F., Martial Coly, B., et al. (2020) Emergency Hemodialysis: A Report of 107 Cases at the Regional Hemodialysis Center of Thies (Senegal). Health Sciences and Disease, 21, 48-52.</mixed-citation></ref><ref id="scirp.131374-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Konan, S.D., Guei, M.C., Diopoh, S.P., Kissou, P.F., Aka, J.A. and Yao, K.H. (2020) First Emergency Hemodialysis Session at the Nephrology Department of Yopougon University Hospital: a Study of 146 Patients. Health Sciences and Disease, 22, 83-87. http://www.hsd-fmsb.org/index.php/hsd/article/view/2838Dis</mixed-citation></ref><ref id="scirp.131374-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Sinomono, D.T., Loumingou, R., Koumou, G.C., Mahoungou, G.H. and Mobengo, J.L. (2021) Chronic Renal Failure in the Brazzaville University Hospital Center: Epidemiological, Clinical and Evolutionary Aspects. Saudi Journal of Kidney Diseases and Transplantation, 32, 1450-1455.</mixed-citation></ref><ref id="scirp.131374-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Agrou, M., Birrou, M., Assal, O., Hikki, N., Ouzeddoun, N., Bayahia, R., et al. (2023) Evolution of Patients with Stage V Chronic Renal Failure and Predictive Factors for Initiation of Dialysis. https://www.academia.edu/download/103338651/7.pdf</mixed-citation></ref><ref id="scirp.131374-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Kazes, I., Béchade, C., Lobbedez, T., Couchoud, C. and Lassalle, M. (2022) Incidence of Stage 5 Chronic Kidney Disease Treated by Replacement and Context of Initiation of Dialysis. Therapeutic Nephrology, 18, 18/5S-e9-18/5S-e14. https://doi.org/10.1016/S1769-7255(22)00562-4</mixed-citation></ref><ref id="scirp.131374-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Nlandu, Y., Hamaz, S., Robert, A., Cheddani, L., Vilaine, è., Seidowsky, A., et al. (2020) End-Stage Renal Failure in the Maghreb and Africa: Overview of Transplantation Programs in the Maghreb and Africa. Therapeutic Nephrology, 16, 171-176. https://doi.org/10.1016/j.nephro.2019.08.001</mixed-citation></ref><ref id="scirp.131374-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Yassine, D. (2012) Prise en charge de l’insuffisance rénale chronique terminale en urgence. Ph.D. Thesis, Morocco.</mixed-citation></ref></ref-list></back></article>